Argutus Medical, a developer of specialised organ injury tests, and a subsidiary of EKF Diagnostics, has introduced RenaStat, its new point-of-care (POC) test.RenaStat was specifically developed to detect the early onset of severe acute kidney injury (AKI) in critical care settings.
The Argutus team can also provide scientific information on the development and use of biomarkers for AKI detection.
www.argutusmed.com
Verulam Scientific Ltd is an analytical instrument company providing innovative solutions and emerging technologies to the UK pharmaceutical, environmental, life science, food, clinical and biotechnology markets. We provide laboratories with the equipment and services that are crucial to modern analytical services and research.
Hyatt Regency, Vancouver, Canada
19-23 November, 2024
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
ICC Ghent, Belgium
24-26 June, 2025
